Table 3.
Pro-cancer activity of antibiotics with their mechanisms of action in different therapy methods via intestinal microbiota imbalance*
| Therapy methods | Antibiotics | Type of Cancer Cell | Mode of Anticancer Activity | Mechanism of Action | Ref |
|---|---|---|---|---|---|
| Surgical treatment | Penicillin | Colon cancer | Abnormal intestinal microbiota count or space position | Immune function damage, the levels of IgA (⭣), IgM (⭣), IgG (⭣) | 65 |
| Radiotherapy | Tetracycline | Breast cancer | Disturb intestinal microbiota | The conversion of glucosinolates, isoflavone and glycosides to biologically active agents (⭣) | 68, 69 |
| Chemotherapy | Macrolides | Breast cancer | Disorder of intestinal microbiota | Regulate immune inflammatory factors, induce chronic inflammation | 72 |
| Tetracyclines & Macrolides | Breast cancer | Disorder of intestinal microbiota | Mitogen-induced T-lymphocyte proliferation (⭣) | 72 | |
| Tetracyclines | Breast cancer | Disorder of intestinal microbiota | Production of PGE2 (⭣) | 71, 73 | |
| Tetracyclines | ――― | Disorder of intestinal microbiota | Production of matrix metalloproteinase (⭣) | 74 | |
| Immunotherapy | Quinolones | Liver cancers | Disrupt the intestinal microbiota | Production direct immunotoxicity (⭡), genotoxicity (⭡), cytotoxicity (⭡) | 76, 77 |
*Up-regulated (⭡). Down-regulated (⭣).